AstraZeneca PLC 26 July 2024 26 July 2024 FDA Advisory Committee reviewed Imfinzi for treatment of resectable non-small cell lung cancer...
AstraZeneca PLC on Thursday raised its annual guidance as it hailed "strong growth in the first half of the year". ...
AstraZeneca PLC 25 July 2024 AstraZeneca 25 July 2024 H1 and Q2 2024 results Strong underlying growth supports FY 2024 guidance upgrade...
AstraZeneca PLC 15 July 2024 15 July 2024 Acquisition of Amolyt Pharma completed AstraZeneca today announced the successful completion of...
AstraZeneca PLC on Friday announced that its medication osimertinib, alongside chemotherapy, has been approved by the ...
Aptamer Group PLC on Wednesday said it reached an agreement with AstraZeneca PLC. The York, England-based biotechnol ...
AstraZeneca PLC 01 July 2024 1 July 2024 15:00 BST Transparency Directive Voting rights and capital The following notification is made...
AstraZeneca PLC on Monday said two cancer treatments had been recommended for approval in the European Union, while t ...
AstraZeneca PLC 01 July 2024 1 July 2024 Lynparza and Imfinzi combination recommended for approval in the EU by CHMP for patients with...
AstraZeneca PLC on Wednesday celebrated the approval of Tagrisso plus chemotherapy for a cancer form in China, a day ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.